olivlawolivlaw

olivLaw · US equity research

MetLife, Inc. MET

Life Insurance · SIC 6311 · Vertical: Life Insurance (SIC 6311)

102.89USD+2.21% · 1 dayClose 04 Nov 2026

MetLife is one of the world's largest financial services companies, active in life insurance, annuities, employee benefits and asset management. In the second quarter of 2026 the company reported higher adjusted earnings, supported by favorable underwriting and volume growth, under its New Frontier strategy. It aims to extend its lead in group benefits and asset management, which makes it relevant to investors and customers following the insurance sector.

The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).

At the close of 04 Nov 2026, MetLife, Inc. (MET) stock was 102.89 USD (+2.21% on the day), with market capitalisation 65.4 bn USD, P/E 19.5 on diluted EPS of 5.27 USD over the last 12 months, dividend yield 2.23%, beta 0.99, 52-week range 67.70–103.57 USD. Latest reported quarter (Q2 2026): revenue of 19.2 bn USD (+10.5% YoY), net income of 736.0 m USD (+1.0% YoY), diluted EPS 1.09 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
65.4 bn USD
shares as of 31 Jul 2026
P/E (TTM)
19.5
Diluted EPS TTM 5.27 · TTM to 30 Jun 2026
E/P (TTM)
5.12%
TTM to 30 Jun 2026
Dividend yield
2.23%
DPS 12m 2.30
Beta (2y)
0.99
Volatility (1y) 24%
52-week range
67.70103.57

Price history

Loading chart…

Technical reading

RSI (14)
61.2
strong (55–70)
Bollinger (20, 2)
97.85 – 103.02
in the upper half of the band · %B 0.97 · band width 5.2%
SMA 50 / 200
98.04 / 86.06
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
1.01 / 0.98
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+6.2%−1.1%+7.3 pp—
3 months+6.9%−0.5%+7.3 pp—
6 months+28.4%+4.4%+24.0 pp—
Year to date+30.3%+12.3%+18.0 pp—
1 year+29.5%+13.5%+15.9 pp+1.1%
3 years+66.6%+76.4%−9.8 pp+41.1%
5 years+60.8%+63.7%−2.9 pp—
Max drawdown (1y)
−18.0%
15 Dec 2025 → 27 Mar 2026
Max drawdown (5y)
−36.2%
25 Nov 2022 → 16 May 2023
Compound annual growth (5y)
+10.0%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q2 2026 · 30 Jun 2026

Revenue
19.2 bn USD
+10.5% YoY
Net income
736.0 m USD
+1.0% YoY
Diluted EPS
1.09
+5.8% YoY
net / operating
3.8% / 8.4%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue18.4 bn18.7 bn18.6 bn17.3 bn17.4 bn23.8 bn19.1 bn19.2 bn
Operating income1.4 bn1.5 bn1.4 bn1.4 bn1.7 bn1.7 bn1.6 bn1.6 bn
Interest expense257.0 m259.0 m258.0 m269.0 m271.0 m263.0 m265.0 m292.0 m
Pre-tax income2.0 bn1.4 bn1.4 bn980.0 m1.2 bn1.1 bn1.5 bn1.0 bn
Income tax653.0 m106.0 m404.0 m245.0 m308.0 m301.0 m345.0 m256.0 m
Net income1.3 bn1.3 bn945.0 m729.0 m896.0 m809.0 m1.2 bn736.0 m
Diluted EPS1.811.82 ≈1.281.031.221.22 ≈1.741.09
Operating cash flow4.2 bn ≈4.6 bn4.3 bn2.2 bn ≈3.6 bn ≈7.1 bn2.7 bn2.2 bn ≈
Dividends paid383.0 m ≈378.0 m374.0 m382.0 m ≈378.0 m ≈375.0 m372.0 m383.0 m ≈
Share repurchases774.0 m ≈406.0 m1.4 bn510.0 m ≈502.0 m ≈460.0 m755.0 m722.0 m ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 88 percentile of its own 40-quarter history (min 3.3, median 11.3, max 72.8; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue67.9 bn69.6 bn67.8 bn68.7 bn68.8 bn66.9 bn71.0 bn77.1 bn
Revenue YoY+9.0%+2.5%−2.6%+1.3%+0.1%−2.7%+6.1%+8.6%
Net income5.1 bn5.9 bn5.4 bn6.9 bn5.3 bn1.6 bn4.4 bn3.4 bn
Net income YoY+27.8%+15.1%−8.3%+26.8%−22.9%−70.1%+180.5%−23.7%
Diluted EPS4.916.065.687.656.301.815.944.71
Diluted EPS YoY+35.6%+23.4%−6.3%+34.7%−17.6%−71.3%+228.2%−20.7%
net %7.5%8.5%8.0%10.0%7.7%2.4%6.2%4.4%
Free cash flowunavailableunavailableunavailableunavailableunavailableunavailableunavailableunavailable

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
22.0 bn USD
Financial debt
355.0 m USD
Net debt
-21.7 bn USD
Equity
28.7 bn USD
Total assets
745.2 bn USD
Debt / equity
0.01x
Current ratio
unavailable
ROE
12.0%
ROA
0.5%
FCF margin
unavailable

Financial statements (source on every figure)

Revenue and net income (USD)

Income statement · USD

Pre-tax income
2023
2.2 bn
2024
5.6 bn
2025
4.7 bn

SEC (XBRL)· 19 Feb 2026verified

Net income
2023
1.6 bn
2024
4.4 bn
2025
3.4 bn

SEC (XBRL)· 19 Feb 2026verified

Diluted EPS
2023
1.81
2024
5.94
2025
4.71

SEC (XBRL)· 19 Feb 2026verified

Dividend per share
2023
2.06
2024
2.16
2025
2.25

SEC (XBRL)· 19 Feb 2026verified

Balance sheet · USD

Cash
2023
20.6 bn
2024
20.1 bn
2025
22.0 bn

SEC (XBRL)· 19 Feb 2026verified

Loans
2023
—
2024
89.0 bn
2025
84.6 bn

SEC (XBRL)· 19 Feb 2026verified

Total assets
2023
687.6 bn
2024
677.5 bn
2025
745.2 bn

SEC (XBRL)· 19 Feb 2026verified

Short-term debt
2023
119.0 m
2024
465.0 m
2025
355.0 m

SEC (XBRL)· 19 Feb 2026verified

Total liabilities
2023
657.3 bn
2024
649.8 bn
2025
716.2 bn

SEC (XBRL)· 19 Feb 2026verified

Equity
2023
30.3 bn
2024
27.7 bn
2025
28.7 bn

SEC (XBRL)· 19 Feb 2026verified

Cash flow · USD

Dividends paid
2023
1.6 bn
2024
1.5 bn
2025
1.5 bn

SEC (XBRL)· 19 Feb 2026verified

Share repurchases
2023
3.1 bn
2024
3.2 bn
2025
2.9 bn

SEC (XBRL)· 19 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
8.6%
computed by olivLawFY 2025
Revenue CAGR 3Y
3.9%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
2.6%
computed by olivLawFY 2020 → FY 2025
Net income growth (YoY)
-23.7%
computed by olivLawFY 2025
Net income CAGR 3Y
-13.8%
computed by olivLawFY 2022 → FY 2025
Net income CAGR 5Y
-9.0%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
-20.7%
computed by olivLawFY 2025
EPS CAGR 3Y
-9.2%
computed by olivLawFY 2022 → FY 2025
EPS CAGR 5Y
-3.7%
computed by olivLawFY 2020 → FY 2025

Profitability

Net margin
4.6%
computed by olivLawTTM to 30 Jun 2026

Returns

ROE
13.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROA
0.5%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Payout ratio (EPS)
43.6%
computed by olivLawTTM to 30 Jun 2026

Market and valuation

Market capitalisation
65.4 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Market cap / net income TTM
18.0x
computed by olivLawTTM to 30 Jun 2026
P/E (TTM)
19.5x
computed by olivLawTTM to 30 Jun 2026
Earnings yield
5.1%
computed by olivLawTTM to 30 Jun 2026
P/B
2.4x
computed by olivLawbalance sheet at 30 Jun 2026
P/S
0.8x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Dividend yield
2.2%
computed by olivLawTTM to 30 Jun 2026
Shareholder yield (distributions)
6.0%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

Insurance

Loss ratio
unavailable
input data missing

32 indicators that do not apply to the sector.

Valuation

olivLaw classification

Unattractive profile

Score: 31 / 100

A scoring methodology on indicators and valuation, not investment advice.

score < 40

Closing price

102.89 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 65.4 bn USD

Key indicators

Market capitalisation
65.4 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
P/E (TTM)
19.5x
computed by olivLawTTM to 30 Jun 2026
P/B
2.4x
computed by olivLawbalance sheet at 30 Jun 2026
ROE
13.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Net margin
4.6%
computed by olivLawTTM to 30 Jun 2026
Revenue growth (YoY)
8.6%
computed by olivLawFY 2025
Dividend yield
2.2%
computed by olivLawTTM to 30 Jun 2026

Coverage and freshness

12/20 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Jun 2026
Latest balance sheet date: 30 Jun 2026
Share count (cover of the latest filing), as of: 31 Jul 2026
Source: SEC (XBRL)published 06 Aug 2026
verified 2190derived 145

Score by group

  • Valuation9
  • Returns69
  • Quality58
  • Balance sheet0
  • Growth17

Estimated value range

Low
29.54
USD per share
Mid
46.92
USD per share
High
52.73
USD per share
Price: 102.89 USD
The price is above the range
Potential to the central value: -54.4% (value / price − 1)
Margin of safety: -119.3% (1 − price / value)
Agreement between methods: low · 5 methods used · 4 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 10.53 – 79.33 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • Residual income45.90 – 47.97 (Mid 46.92)
  • Justified P/B58.99 – 79.33 (Mid 67.66)
  • Dividend discount (DDM)29.54 – 39.73 (Mid 33.89)
  • Peers: P/E18.50 – 68.32 (Mid 48.07)
    16 companies used · median multiple 9.1x · quartiles 3.5x – 13.0x
    AAME, ANG-PD, ATHS, BHF, CIA, CRBD, FG, GL, GNW, JXN, LNC, PFH, PRI, PUK, RGA, VOYA
  • Peers: P/B10.53 – 52.73 (Mid 28.71)
    14 companies used · median multiple 0.7x · quartiles 0.2x – 1.2x
    AAME, ANG-PD, ATHS, BHF, CIA, CRBD, FG, GL, GNW, JXN, LNC, PFH, RGA, VOYA
Multiple comparisons use the SIC vertical: Life Insurance (SIC 6311)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Unattractive profile · Score 31/100

FactorValueScoreWeight used
ROE · Quality13.2%58 (vs peers)20%
Loss ratio · Qualityunavailableunavailable—
EPS CAGR 3Y · Growth-9.2%0 (on a fixed band)11%
Revenue CAGR 3Y · Growth3.9%39 (on a fixed band)9%
ROA · Balance sheet0.5%0 (on a fixed band)9%
P/B · Valuation2.4x19 (vs peers)16%
P/E (TTM) · Valuation19.5x0 (vs peers)16%
Dividend yield · Returns2.2%54 (vs peers)11%
Payout ratio (EPS) · Returns43.6%95 (on a fixed band)7%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet0/100 · 1/1 factors with a value
  • Growth17/100 · 2/2 factors with a value
  • Quality· partial58/100 · 1/2 factors with a value
  • Returns69/100 · 2/2 factors with a value
  • Valuation9/100 · 2/2 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

MetLife, Inc. (MET). Latest full fiscal year: 2025; data up to 2026-06-30.

Figures computed from the financial statements: YoY growth 8.6%; net margin 4.6%; ROE 13.2%.

The estimated value range is 29.54–52.73 USD per share (median of 5 methods, agreement: low); assumptions are illustrative. Against the central value of 46.92 USD, the price of 102.89 USD leaves a potential of -54.4% (value / price − 1) and a margin of safety of -119.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 31/100, methodological classification: unattractive profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: quality. Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • Payout ratio (EPS): 43.6%

What contradicts it

  • EPS CAGR 3Y: -9.2%
  • ROA: 0.5%
  • P/B: 2.4x
  • P/E (TTM): 19.5x
  • The price is above the estimated value range
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): Loss ratio.

Versus the vertical median

Life Insurance (SIC 6311) · same industry (4-digit SIC) · compared with 19 companies

The size band was not applied: too few companies would have remained; the vertical includes much smaller or larger companies.

Multiples and returns vs the median

P/E
19.5x
vertical median 9.1x
above median (+114.1%)
EV/EBITDA
—
vertical median —
P/S
0.8x
vertical median 0.5x
above median (+74.0%)
P/B
2.4x
vertical median 0.8x
above median (+199.5%)
ROE
13.2%
vertical median 11.7%
above median (+12.2%)
Net margin
4.6%
vertical median 9.5%
below median (−52.1%)
EBIT margin
—
vertical median —
Revenue YoY
8.6%
vertical median 4.3%
above median (+98.3%)
Net debt/EBITDA
—
vertical median —
Dividend yield
2.2%
vertical median 1.8%
above median (+24.2%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
PUKPrudential PLC67.2 bn17.221.2%34.6%+7.0%−10% / +20%
METMetLife, Inc.65.4 bn19.513.2%4.6%+8.6%+29% / +67%
RGAReinsurance Group Of America, Incorporated17.4 bn11.711.7%5.8%+7.2%+40% / +64%
GLGlobe Life Inc.12.2 bn10.819.3%18.9%+3.7%+20% / +31%
VOYAVoya Financial, Inc.9.3 bn16.714.3%7.8%+1.7%+49% / +46%
CRBDCorebridge Financial, Inc.9.3 bn4.621.7%10.6%−1.2%−11% / unavailable
JXNJackson Financial Inc.9.1 bn11.19.5%13.4%+104.3%+40% / +188%
PRIPrimerica, Inc.8.8 bn11.433.0%23.2%+6.6%+11% / +36%
LNCLincoln National Corp8.0 bn3.622.6%12.2%−1.2%+1% / +75%
PFHPrudential Financial, Inc.5.3 bn1.412.6%6.3%−13.7%−11% / −20%
GNWGenworth Financial, Inc.3.5 bn17.52.4%2.9%+0.1%+6% / +56%
FGF&G Annuities & Life, Inc.2.9 bn7.49.2%6.9%−0.2%−32% / −46%
BHFBrighthouse Financial, Inc.2.4 bn3.313.6%12.5%+43.2%−35% / −18%
CIACitizens, Inc.209.2 m18.05.0%4.5%+4.3%−31% / +25%
AAMEAtlantic American Corporation24.3 m4.35.2%2.9%+11.9%−51% / −39%
ATHSAthene Holding Ltd4.7 m0.04.5%2.9%+24.1%−8% / unavailable
ANG-PDAmerican National Group Inc.215.5 k0.08.4%12.6%−0.4%−15% / unavailable
SLFSun Life Financial Inc——14.2%8.5%+8.0%+39% / +62%
MFCManulife Financial Corporation——11.0%68.5%+7.1%+31% / +135%
AEGAegon Ltd.——10.5%—+1.1%+7% / +56%

1- and 3-year price returns: for MET from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
65.42
Total return -35% · Per year -35%
115.69
Total return 15% · Per year 15%
174.31
Total return 72% · Per year 72%
3 years
62.70
Total return -34% · Per year -13%
124.83
Total return 29% · Per year 9%
206.63
Total return 111% · Per year 28%
5 years
60.09
Total return -33% · Per year -8%
134.70
Total return 44% · Per year 8%
244.95
Total return 156% · Per year 21%
What moves the 3-year price the most
  • Exit P/E± 31.21
  • Net margin± 21.85
  • Annual revenue growth± 18.04
  • Annual dilution± 1.84

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results).

In brief

MetLife is one of the world's largest financial services companies, active in life insurance, annuities, employee benefits and asset management. In the second quarter of 2026 the company reported higher adjusted earnings, supported by favorable underwriting and volume growth, under its New Frontier strategy 3. It aims to extend its lead in group benefits and asset management, which makes it relevant to investors and customers following the insurance sector.

SWOT

Strengths

  • Geographic and product diversification, together with a leading position in US group benefits, provides stability and supports consistent results 13.
  • A global brand and the ability to generate cash for shareholders support the company's financial flexibility 1.
  • Growth in adjusted earnings and adjusted return on equity at high levels point to solid operational execution 3.

Weaknesses

  • High exposure to interest rate movements and capital markets can affect margins and the value of the investment portfolio 1.
  • Reported net income can be affected by investment and derivative items, making reported results more volatile than adjusted results 3.
  • Operations in many countries bring operational complexity and exposure to currency and political risks 1.

Opportunities

  • Expansion in asset management, supported by the PineBridge acquisition, could increase fee-based revenues 13.
  • Growth in Asian and Latin American markets could support sales volumes in the coming years 3.
  • If the New Frontier strategy delivers as planned, medium-term profitability targets could be reached 1.

Threats

  • An economic downturn or financial market volatility could reduce assets under management and fee income 1.
  • Regulatory changes and litigation may alter distribution conditions and compliance costs 2.
  • Intense competition in insurance and asset management could put pressure on prices and margins 2.

Risks

  • Interest rate riskhigh

    Rising or falling interest rates can reduce investment margins and change liability costs, affecting profitability 1.

  • Capital market riskhigh

    Declines or volatility in equity markets can reduce revenue from investment-linked products and the value of alternative investments 1.

  • Counterparty riskmedium

    Failure of reinsurers or other counterparties to meet obligations can cause losses, even where collateral exists 1.

  • Currency riskmedium

    Exchange rate movements against the US dollar can affect reported results of foreign subsidiaries 1.

  • Regulatory risklow

    Changes to fiduciary and pension rules could alter distribution models and advisory practices 2.

Investment thesis

What would need to be true (bull case)

  • Growth in adjusted earnings and adjusted return on equity at the top of the target range suggest the New Frontier strategy is producing concrete results 3.
  • Diversification across segments and regions may help the company remain stable if one market weakens 1.
  • Expansion in asset management, supported by a recent acquisition, could add long-term recurring revenue 13.

What would break the thesis

  • Reported results can be much more volatile than adjusted results if investment and derivative items become significant 3.
  • Exposure to interest rates and capital markets could reduce margins if the economic environment deteriorates 1.
  • Strong competition in insurance and asset management could limit growth or pressure pricing conditions 2.

What to watch

  • Quarterly results and the trend in adjusted earnings per shareQ3 2026
  • Development of MIM assets under management after the PineBridge integration2026
  • Achievement of the direct expense ratio target and adjusted return on equity2026

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results).

The business

MetLife, Inc. is one of the most important financial services companies in the world, offering insurance, annuities, employee benefits and asset management services 1. It holds major market positions in the United States, Asia, Latin America, Europe and the Middle East 1. From the fourth quarter of 2025 MetLife reorganized its segments, so activity is reported in six segments: Group Benefits, RIS, Asia, Latin America, EMEA and MIM, plus Corporate & Other 1.

The New Frontier strategy, introduced at a December 2024 Investor Day, targets four areas: extending the lead in Group Benefits, capitalizing on the retirement platform, accelerating growth in asset management and expanding in high growth international markets 1. The acquisition of PineBridge Investments, completed on December 30, 2025 by the MIM division, supports the asset management growth direction 1.

The company is also one of the largest institutional investors in the United States, with a general account portfolio invested mainly in fixed income securities and mortgage loans, as well as real estate and other assets 1. MetLife's quarterly results show higher adjusted earnings and an adjusted return on equity of 17% in the second quarter of 2026 3.

Segments

Group Benefits

The Group Benefits segment, based in the United States, offers life, dental, disability, paid family and medical leave, and vision and accident and health insurance to employers 1. In the second quarter of 2026 segment adjusted earnings rose 25% to 503 million USD, supported by favorable underwriting and volume growth 3.

Market context

The life insurance and institutional asset management industries are highly competitive, and MetLife's results depend on global financial conditions, the level of interest rates and the value of assets under management 12. The company reports that premiums, fees and other revenues rose 7% in the second quarter of 2026, pointing to solid demand across several segments 3.

Regulatory changes in pensions and investment advice, as well as central bank monetary policies, can influence both costs and product appeal 2. The company monitors tariffs, sanctions and changes to international trade agreements as factors that could affect its business 2.

Trends

  • Interest ratesmixed

    The level of interest rates affects portfolio returns and the cost of liabilities; a rise could improve margins, while a prolonged decline could reduce investment income 1.

  • Pension regulationmixed

    Regulatory changes on the definition of an investment advice fiduciary under ERISA were partly vacated by court orders, which changes the compliance framework for distributors 2.

  • Competitive pressureheadwind

    Intense competition in insurance and asset management could limit volume growth or margins if rival products offer more attractive terms 2.

Competitive position

MetLife competes with other global providers of life insurance, employee benefits and annuities, as well as with asset managers offering institutional services 12. Competitive pressure is felt in the United States as well as in the Asian and Latin American markets 1.

Geographic and product diversification can help the company meet competition, but exposure to different markets brings risks specific to each region 1. Its leading position in Group Benefits in the United States is supported by long-standing relationships with large employers 1.

  • Prudential FinancialPRU

    Direct competitor in life insurance and retirement products in the United States, cited within the competitive industry described in the SEC sources.

  • Principal Financial GroupPFG

    Provider of employee benefits and institutional asset management, competing in the retirement and Group Benefits segments.

  • AIA Group

    Major insurer in Asia, competing with the company's Asia segment in fast growing markets.

  • Allianz

    European insurance and asset management group, competing in European markets and in institutional asset management.

News & filings

In the press

The latest news item in our archive is from 13 Oct 2026; the newest SEC filing is from 04 Nov 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.

SEC filings

  • Current report04 Nov 2026
    Results of operations · Regulation FD disclosure · Other events · Financial statements and exhibits
  • Current report24 Sept 2026
    Regulation FD disclosure
  • Current report17 Aug 2026
    Other events · Financial statements and exhibits
  • Quarterly report06 Aug 2026
  • Current report05 Aug 2026
    Results of operations · Regulation FD disclosure · Other events · Financial statements and exhibits
  • Current report29 Jun 2026
    Regulation FD disclosure
  • Current report22 Jun 2026
    Shareholder vote
  • Current report15 May 2026
    Other events · Financial statements and exhibits
  • Quarterly report07 May 2026
  • Current report06 May 2026
    Results of operations · Regulation FD disclosure · Other events · Financial statements and exhibits

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / MetLife, Inc. · 19 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / MetLife, Inc. · 06 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / MetLife, Inc. · 05 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.